Exact Sciences Corporation
EXAS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10 | $10 | $8 | $10 |
| - Cash | $1 | $1 | $0 | $1 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $12 | $12 | $10 | $13 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 4.9% | 14.8% | -0.9% | – |
| Gross Profit | $1 | $1 | $1 | $0 |
| % Margin | 68.6% | 69.3% | 70.8% | 60.2% |
| EBITDA | $0 | $0 | -$0 | -$1 |
| % Margin | 4.5% | 6.6% | -5.4% | -114.2% |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | -2.3% | -0.1% | -14.3% | -121.2% |
| EPS Diluted | -0.1 | -0.006 | -0.54 | -4.67 |
| % Growth | -1,487.3% | 98.8% | 88.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |